
Jim Middleton, BS, RPh
Advertisement
Articles by Jim Middleton, BS, RPh
Advertisement
Latest Updated Articles
PRODUCT profilesNovember 1st 2007
A closer look at new FDA actionsSeptember 1st 2007
A closer look at new FDA actionsAugust 1st 2007
generic times product newsJuly 1st 2007
generic times: product profilesMay 1st 2007
generic times: product profilesApril 1st 2007
Advertisement
Advertisement
Trending on Pharmacy Times
1
Teclistamab-Daratumumab Intensification Achieves 73% MRD-Negative CR Rate in High-Risk Multiple Myeloma
2
After 180 Years, Multiple Myeloma Gets a Definition of Cure
3
Nearly Two-Thirds of Patients With Long COVID Meet Diagnostic Criteria for POTS
4
Psilocybin-Assisted Therapy for AUD: Emerging Evidence, Clinical and Cost Implications, and Treatment Gaps
5